Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 82.00 | 76.75 | 1.0684 | 1.5280 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 88.00 | 76.75 | 1.1466 | 2.2461 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 96.00 | 76.75 | 1.2508 | 3.4173 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 99.00 | 76.75 | 1.2899 | 3.9258 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 79.00 | 76.75 | 1.0293 | 1.2154 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 75.00 | 76.75 | 0.9772 | 0.8432 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 79.00 | 76.75 | 1.0293 | 1.2154 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 46.00 | 76.75 | 0.5994 | -0.6735 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 71.00 | 76.75 | 0.9251 | 0.5180 | |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 70.00 | 76.75 | 0.9121 | 0.4437 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 156.25 | 63.10 | 44.00 | 76.75 | 0.5733 | -0.7211 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 79.00 | 76.75 | 1.0293 | 1.2154 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 156.25 | 63.10 | 110.00 | 76.75 | 1.4332 | 6.1530 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 156.25 | 63.10 | 90.00 | 76.75 | 1.1726 | 2.5149 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 156.25 | 63.10 | 641.00 | 76.75 | 8.3518 | 3669.7801 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 4 | 156.25 | 63.10 | 53.00 | 76.75 | 0.6906 | -0.4609 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 156.25 | 63.10 | 48.00 | 76.75 | 0.6254 | -0.6204 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 156.25 | 63.10 | 111.00 | 76.75 | 1.4463 | 6.3859 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 156.25 | 63.10 | 115.00 | 76.75 | 1.4984 | 7.3723 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 156.25 | 63.10 | 2890.00 | 76.75 | 37.6547 | 759459.5199 |
| SK-BR-3 | Nilotinib | 1 | uM | 4 | 156.25 | 63.10 | 77.00 | 76.75 | 1.0033 | 1.0232 |
| SK-BR-3 | 0 | uM | 4 | 156.25 | 63.10 | 127.00 | 76.75 | 1.6547 | 10.8978 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 156.25 | 63.10 | 69.00 | 76.75 | 0.8990 | 0.3720 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 156.25 | 63.10 | 66.00 | 76.75 | 0.8599 | 0.1722 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 156.25 | 63.10 | 74.00 | 76.75 | 0.9642 | 0.7576 |